Advertisement

Topics

Update March 14, 2018: Lattice Biologics Ltd. Management Cease Trade Order

09:00 EDT 14 Mar 2018 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Lattice Biologics Ltd. (TSX-V: LBL) (OTCQB: LBLTF) (“Lattice Biologics” or the “Company”) is providing this default status report in accordance with National Policy 12-203 – Management Cease Trade Orders. The C...

Other Sources for this Article

Lattice Biologics Ltd.
Cheryl Farmer, CFO, 480-563-0800
News@LatticeBiologics.com
www.LatticeBiologics.com

NEXT ARTICLE

More From BioPortfolio on "Update March 14, 2018: Lattice Biologics Ltd. Management Cease Trade Order"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...